Rayment Kevin 4
4 · CURTISS WRIGHT CORP · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
Curtiss‑Wright (CW) EVP/COO Kevin Rayment Sells Shares
What Happened Kevin Rayment, Executive Vice President and COO of Curtiss‑Wright (CW), had 2,504 restricted stock units (RSUs) cliff‑vest on March 16, 2026 (grant dated March 16, 2023). Those RSUs converted to 2,504 shares (reported as an exercise/conversion of a derivative, code M, at $0.00 because the award was an employee benefit). Following the vesting, Rayment sold 907 shares in open‑market transactions on March 17, 2026, for aggregate proceeds of $614,384 (average price $677.38; sale prices ranged $671.52–$681).
Key Details
- Transaction dates: RSU conversion (exercise/conversion) on 2026‑03‑16; open‑market sale on 2026‑03‑17.
- Shares converted/acquired: 2,504 shares (RSU cliff vest).
- Shares sold: 907 shares, total proceeds $614,384; average sale price $677.38 (range $671.52–$681). Reporting person can provide per‑trade prices to the SEC/issuer.
- Price of conversion reported as $0.00 because RSUs were granted as employee compensation.
- Footnotes: RSUs granted 3/16/2023 with three‑year cliff vesting (F1); sale conforms with company share ownership guidelines and was used in part to cover tax obligations (F3); totals include dividend credits on prior grants (F5).
- Shares owned after the transaction: Not specified in the Form 4 filing.
- Filing timeliness: Report filed 2026‑03‑18 for transactions on 2026‑03‑16/17; appears timely (Form 4 typically due within two business days).
Context This was not an open‑market purchase but a vesting of previously granted RSUs followed by a partial sale. The sale is described in the filing as routine (to cover tax obligations) and the reporting person remains in compliance with company ownership guidelines. Conversions of RSUs reported at $0 reflect that the shares were issued as compensation rather than purchased.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1][F2]2026-03-16+2,504→ 32,400 total - Sale
Common Stock
[F3][F4]2026-03-17$677.38/sh−907$614,384→ 31,493 total - Exercise/Conversion
Restricted Stock Unit
[F2][F1][F5]2026-03-16−2,504→ 3,928 totalExercise: $0.00From: 2026-03-16Exp: 2026-03-16→ Common Stock (2,504 underlying)
Footnotes (5)
- [F1]These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
- [F2]No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
- [F3]Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
- [F4]The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.52 to $681, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
- [F5]Share total includes dividend credits earned on prior outstanding grants.